MedTrace Logo

Effect of Artronat on the Quality of Life of Patient With Osteoarthritis

NCT01356199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2014-03-18

No results posted yet for this study

Summary

The purpose of this study is to determine whether the nutritional supplement ARTRONAT improves the quality of life of patients with osteoarthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

ARTRONAT

Dietary supplement containing Glucosamine, Chondroïtine and manganese. 6 per day for 8 months.

DIETARY_SUPPLEMENT

PLACEBO

PLACEBO. 6 per day for 8 months.

Sponsors & Collaborators

  • RDVC Produit de Santé.

    collaborator UNKNOWN

  • Association Nationale de Prévention Médicale.

    collaborator UNKNOWN

  • Lescuyer Laboratory

    lead INDUSTRY

Principal Investigators

  • Maurice Cloarec, MD · Association Nationale de Prevention Medicale

  • Dominique Baron, MD · Hospital Center of Lanion

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-01-31
Completion
2013-12-31

Countries

  • France

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01356199 on ClinicalTrials.gov